Project Details
Description
N/A
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/13 → 4/1/14 |
A phase III clinical trial to study the tolerability and immunogenicity of V503, a multivalent human papillomavirus (HPV) L1 virus-like particle (BLP) vaccine, in 16- to 26-year-olds and 16- to 26-year-olds in women V5003-003-0069
Project: Research Project